These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2882973)

  • 1. In vivo metabolism of the leukotriene receptor antagonist, 5-(2-dodecylphenyl)-4,6-dithianonanedioic acid (SK&F 102,081) in the guinea pig.
    Newton JF; Straub KM; Kuo GY; Perchonock CD; McCarthy ME; Gleason JG; Lynn RK
    Drug Metab Dispos; 1987; 15(2):168-76. PubMed ID: 2882973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of the leukotriene receptor antagonist 5-(2-(8-phenyloctyl)phenyl)-4,6-dithianonanedioic acid (SK&F 102922) in the guinea pig. Rearrangement of the acyl glucuronide.
    Newton JF; Straub KM; Dewey RH; Perchonock CD; McCarthy ME; Gleason JG; Lynn RK
    Drug Metab Dispos; 1992; 20(4):479-84. PubMed ID: 1356721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro microsomal metabolism of the leukotriene receptor antagonist, 5-(2-dodecylphenyl)-4,6-dithianonanedioic acid (SK&F 102,081).
    Newton JF; Straub KM; Dewey RH; Perchonock CD; Leonard TB; McCarthy ME; Gleason JG; Eckardt RD
    Drug Metab Dispos; 1987; 15(2):161-7. PubMed ID: 2882972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
    Potts W; van Horn R; Anderson K; Blake T; Garver E; Joseph G; Dreyer G; Shu A; Heys R; Fong KL
    Drug Metab Dispos; 1995 Aug; 23(8):799-805. PubMed ID: 7493545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
    Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA
    Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of trimoprostil metabolites excreted in rat bile formed by oxidation and taurine conjugation.
    Kolis SJ; Postma EJ; Williams TH; Sasso GJ
    Drug Metab Dispos; 1986; 14(4):465-70. PubMed ID: 2873994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ractopamine hydrochloride metabolites excreted in rat bile.
    Smith DJ; Giddings JM; Feil VJ; Paulson GD
    Xenobiotica; 1995 May; 25(5):511-20. PubMed ID: 7571724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of citral, an alpha,beta-unsaturated aldehyde, in male F344 rats.
    Diliberto JJ; Srinivas P; Overstreet D; Usha G; Burka LT; Birnbaum LS
    Drug Metab Dispos; 1990; 18(6):866-75. PubMed ID: 1981530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
    Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
    Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
    Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
    Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of etretinate metabolites in human bile.
    Vane FM; Buggé CJ; Rodriguez LC
    Drug Metab Dispos; 1989; 17(3):275-9. PubMed ID: 2568908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of cysteinyl leukotrienes and their metabolites in bile of patients with peroxisomal or mitochondrial beta-oxidation defects.
    Mayatepek E; Ferdinandusse S; Meissner T; Wanders RJ
    Clin Chim Acta; 2004 Jul; 345(1-2):89-92. PubMed ID: 15193981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
    Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy.
    Colizza K; Awad M; Kamel A
    Drug Metab Dispos; 2007 Jun; 35(6):884-97. PubMed ID: 17360832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereospecificity of flobufen metabolism in guinea pigs in vitro and in vivo: phase I of biotransformation.
    Kral R; Skalova L; Szotakova B; Babu YN; Wsol V
    Chirality; 2004 Jan; 16(1):1-9. PubMed ID: 14628293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major routes of naftifine biotransformation in laboratory animals and man.
    Schatz F; Haberl H; Battig F; Jobstmann D; Schulz G; Nefzger M; Czok R; Nikiforov A
    Arzneimittelforschung; 1986 Feb; 36(2):248-55. PubMed ID: 3964331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations.
    Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR
    Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of alpha-phosphonosulfonate squalene synthase inhibitors. I. Disposition of a farnesylethyl alpha-phosphonosulfonate and ester prodrugs in rats.
    Lan SJ; Hsieh DC; Hillyer JW; Fancher RM; Rinehart KJ; Warrack BM; White RE
    Drug Metab Dispos; 1998 Oct; 26(10):993-1000. PubMed ID: 9763405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.